At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Douglas Easton, PhD, from the University of Cambridge, Cambridge, United Kingdom, provides an overview of the opportunities and challenges associated with applying the knowledge of a patients genetic susceptibility for breast cancer in clinical management, including the potential to individualise breast cancer screening and risk-reduction measures.
European Medical Journal
Website: http://emjreviews.com/
Twitter: https://twitter.com/EMJReviews
Facebook: https://www.facebook.com/emjreviews
Advertisement